ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,712.69
-0.28%
US Tech 100
19,491.20
0.26%
Dow Jones
41,794.60
-0.61%
Brent Oil
75.295
0.24%
Bitcoin
68,727.12
1.34%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sienna Biopharmaceuticals Inc (SNNA) Quote

Sienna Biopharmaceuticals Inc

Sienna Biopharmaceuticals Inc (SNNA)

NASDAQ
0.1358
0.00
(0.00%)
Closed November 04 4:00PM
Delayed by 15 minutes
0.1358
0.00
( 0.00% )
Pre Market: 7:00PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.1358
Bid
0.1382
Ask
0.1398
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.1358
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

SNNA Latest News

More News

Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna Biopharmaceuticals

Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna Biopharmaceuticals Appoints Chuck Abraham as Chief Executive Officer Acquires...

January 09 2020
PR Newswire (US)

Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures

WESTLAKE VILLAGE, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) (the “Company”), a clinical-stage biopharmaceutical company, today announced that, on...

November 14 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting Notice

-- Sienna’s common stock to remain conditionally listed during the Chapter 11 asset sale process WESTLAKE VILLAGE, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc...

November 14 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove L...

WESTLAKE VILLAGE, Calif., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that the Company has filed...

October 07 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding

WESTLAKE VILLAGE, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that it has elected to...

September 17 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives

WESTLAKE VILLAGE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that the Company has...

August 05 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference

WESTLAKE VILLAGE, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Frederick C...

June 20 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals Announces Late-Breaking Oral Presentation of Phase 2b Trial Results of its Topical, Non-Steroidal T...

-- Phase 2b Trial Results Demonstrated SNA-120 Had Significant Impact on Psoriasis and Was Well-Tolerated WESTLAKE VILLAGE, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals...

June 10 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals to Present at Dermatology Drug Development Summit Europe

WESTLAKE VILLAGE, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Paul F. Lizzul, M.D...

May 21 2019
GlobeNewswire Inc.

Sienna Biopharmaceuticals Announces SNA-120 (0.05%) Biopsy Data Demonstrate Positive Impact on Key Inflammatory Cytokines, in...

-- Biopsy data support strong clinical effect observed in Phase 2 trials with SNA-120  -- Following Positive End-of-Phase 2 meeting with FDA, Sienna continues toward enrolling first patient in...

May 14 2019
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNOXBionomics Ltd
$ 0.36
(88.25%)
25.93M
SPPLSIMPPLE Ltd
$ 1.99
(68.64%)
12.75M
ALBTAvalon GloboCare Corporation
$ 3.24
(44.64%)
2.62M
QNSTQuinStreet Inc
$ 27.05
(33.91%)
2.12k
ALABAstera Labs Inc
$ 87.00
(24.91%)
242.24k
MQMarqeta Inc
$ 3.67
(-38.32%)
299k
VRCAVerrica Parmaceuticals Inc
$ 0.95
(-33.57%)
24.68k
GANXGain Therapeutics Inc
$ 1.40
(-32.37%)
20
FAASDigiAsia Corporation
$ 0.68
(-24.44%)
37
NVTSNavitas Semiconductor Corporation
$ 2.10
(-19.54%)
38.9k
BNOXBionomics Ltd
$ 0.36
(88.25%)
25.93M
ELABElevai Labs Inc
$ 0.0231
(14.93%)
24.81M
SPPLSIMPPLE Ltd
$ 1.99
(68.64%)
12.75M
DJTTrump Media and Technology Group Corporation
$ 36.38
(5.94%)
2.84M
ALBTAvalon GloboCare Corporation
$ 3.24
(44.64%)
2.62M

Discussion

View Full Feed
NorOilGuy1 NorOilGuy1 4 minutes ago
what's going to happen
GSPE
tw0122 tw0122 6 minutes ago
Ketoair to the rescue measure keto levels with your breath $3.14 +'40%
ALBT
Chiron Chiron 8 minutes ago
.0015 will hit soon
ASII
capgain capgain 8 minutes ago
You too.
misterfishman misterfishman 9 minutes ago
The bashing is strong here.
ASII
tw0122 tw0122 11 minutes ago
Happy to exit average was .23. Exit at .43s. This one was a good dump and wait for the pump candidate 
BNOX
TRAPPER JIM TRAPPER JIM 11 minutes ago
Up early so I can go vote before I go to work this morning. Me and Mali just got done eating breakfast 
misterfishman misterfishman 11 minutes ago
Bro your test levels drop as you age dhea helps to restore the balance it's for every older bro here to looking it including you if your over 50 yrs what romance are you talking about.everyone should care about their fellow human bieng and leave this world a better place you have some growing up and
IGPK
Running Wild Running Wild 12 minutes ago
You know it's over when all the big P&D bagholders come on the board screaming how much they made. So insecure.

Lolzzzzzzzzz

And sooooo predictable.


As The NSAV World Burns 🔥🔥🔥🔥🔥
NSAV
tw0122 tw0122 13 minutes ago
Time to exit trade as Chinese markets been predictors of US elections and very green this morning. Trump was going to kill China imports with Tariffs. Caution 
PHUN
Omar8 Omar8 17 minutes ago
Rocketred,



"PAU HOLE 1 will it be grades like Aurelian Resources ?


I'm hoping not just Hole 1 is, but those other recent one are as well. I believe I heard the CEO say in a video or two they have proven the historical 2 million average but are wa
PVGDF
ksquared ksquared 18 minutes ago
Morning, cap.
Busy day ahead.
I'll be lying low.
Have a good one.
tw0122 tw0122 20 minutes ago
China markets very green saying Harris the winner because Trump was planning on harsh Chinese tariff's
YINN
wmbz-sc wmbz-sc 21 minutes ago
http://www.321gold.com/editorials/moriarty/moriarty110524.html
WHGOF
capgain capgain 24 minutes ago
Let us pray!
capgain capgain 25 minutes ago
Yes, Sir!
capgain capgain 25 minutes ago
Good morning, Ks
Bull_Dolphin Bull_Dolphin 27 minutes ago
Next up....

Vance 2028!
jimr1717 jimr1717 29 minutes ago
With the SINT Reverse~Split history one may find it hard to find a larger pos.

This thing has to have made the Forbes best Tax Loss investments top 10 for several years.

So if it’s a future loss that you are looking for, look no further.
SINT
Number sleven Number sleven 30 minutes ago
https://www.bioworld.com/articles/714134-australia-reimburses-vazkepa-a-decade-after-us-approval?v=preview
Sleven,
AMRN
SkeBallLarry SkeBallLarry 31 minutes ago
" The left has had plenty of time to >

find-a-way, Captain ~

I hope Mr. Trump is taking names " .. !!

Your Recent History

NASDAQ
SNNA
Sienna Biopharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved